Pratiba Irudayaraj Access

She is currently focused on "augmentation over automation." While many fear AI replacing jobs, Pratiba sees it as a tool to eliminate the mundane, allowing knowledge workers to return to what humans do best: critical thinking, negotiation, and creativity. Her recent thought leadership focuses on building "AI-resilient" career paths for mid-level managers who are most vulnerable to the technology shift.

: Irudayaraj has explored synthetic nucleic acid delivery for monoclonal antibodies , a vital area for enhancing the body's immune response to infections. Pratiba Irudayaraj

: She has published extensive overviews of SARS-CoV-2 viral proteins , examining how these structures can be leveraged to improve diagnostic and therapeutic platforms. She is currently focused on "augmentation over automation

(Cell & Molecular Biology) at Eurofins Lancaster Laboratories (2018–2019). Technical Expertise : Specialized in molecular biology techniques such as , DNA extraction for Next Generation Sequencing (NGS) , and bioassay method development within GMP-regulated environments. Scientific Contributions : She has published extensive overviews of SARS-CoV-2